Cargando…
Circulating Tumor Cells Identify Early Recurrence in Patients with Non-Small Cell Lung Cancer Undergoing Radical Resection
BACKGROUND: Surgery is the treatment of choice for patients with non-small cell lung cancer (NSCLC) stages I-IIIA. However, more than 20% of these patients develop recurrence and die due to their disease. The release of tumor cells into peripheral blood (CTCs) is one of the main causes of recurrence...
Autores principales: | Bayarri-Lara, Clara, Ortega, Francisco G., Cueto Ladrón de Guevara, Antonio, Puche, Jose L., Ruiz Zafra, Javier, de Miguel-Pérez, Diego, Ramos, Abel Sánchez-Palencia, Giraldo-Ospina, Carlos Fernando, Navajas Gómez, Juan A., Delgado-Rodriguez, Miguel, Lorente, Jose A., Serrano, María Jose |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4767413/ https://www.ncbi.nlm.nih.gov/pubmed/26913536 http://dx.doi.org/10.1371/journal.pone.0148659 |
Ejemplares similares
-
Post-Surgery Circulating Tumor Cells and AXL Overexpression as New Poor Prognostic Biomarkers in Resected Lung Adenocarcinoma
por: de Miguel-Pérez, Diego, et al.
Publicado: (2019) -
Cooperative and Escaping Mechanisms between Circulating Tumor Cells and Blood Constituents
por: Garrido-Navas, Carmen, et al.
Publicado: (2019) -
Circulating tumor cells criteria (CyCAR) versus standard RECIST criteria for treatment response assessment in metastatic colorectal cancer patients
por: Delgado-Ureña, Mayte, et al.
Publicado: (2018) -
miRNA in situ hybridization in circulating tumor cells - MishCTC
por: Ortega, Francisco G., et al.
Publicado: (2015) -
A comprehensive study of circulating tumour cells at the moment of prostate cancer diagnosis: biological and clinical implications of EGFR, AR and SNPs
por: Puche-Sanz, Ignacio, et al.
Publicado: (2017)